Bionano Genomics (BNGO) Assets Average (2018 - 2026)

Bionano Genomics' Assets Average history runs 9 years deep, the most recent figure standing at $69.2 million for Q1 2026.

• In Q1 2026, Assets Average fell 10.77% year-over-year to $69.2 million; the TTM figure through Mar 2026 stood at $69.2 million (down 10.77% YoY), while the FY2025 annual figure was $75.1 million, down 48.38% from the prior year.
• Assets Average came in at $69.2 million for Q1 2026 at Bionano Genomics, down from $76.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $362.7 million in Q1 2022 to a low of $69.2 million in Q1 2026.
• A 5-year average of $190.6 million and a median of $186.2 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 62.88% in 2022 and plunged 58.61% in 2024, its largest moves.
• Bionano Genomics' Assets Average stood at $315.6 million in 2022, then plunged by 37.21% to $198.2 million in 2023, then tumbled by 58.61% to $82.0 million in 2024, then fell by 6.94% to $76.3 million in 2025, then retreated by 9.34% to $69.2 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $69.2 million, $76.3 million, and $77.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison